Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
Cash from Operating Activities
Kamada Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Operating Activities
$4.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Operating Activities
-$2.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Cash from Operating Activities
-$22.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Operating Activities
-$76.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Operating Activities
-$7.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Operating Activities
-₪26.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-12%
|
See Also
What is Kamada Ltd's Cash from Operating Activities?
Cash from Operating Activities
4.3m
USD
Based on the financial report for Dec 31, 2023, Kamada Ltd's Cash from Operating Activities amounts to 4.3m USD.
What is Kamada Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-16%
Over the last year, the Cash from Operating Activities growth was -85%. The average annual Cash from Operating Activities growth rates for Kamada Ltd have been -39% over the past three years , -16% over the past five years .